Courtesy of Newswise MedNews. A new clinical trial at the University of North Carolina at Chapel Hill using a popular low-dose contraceptive could uncover a more effective treatment for the 5 to 10 percent of women who suffer from premenstrual dysphoric disorder (PMDD). http://newswise.com/articles/view/543573/
Link to this comment:
All Comments (0)